Asset Dedication LLC
TEVA icon

Asset Dedication LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Asset Dedication LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-198
Closed -$6.71K – 1297
2026
Q2 		$6.71K Buy
+198
New +$6.6K ﹤0.01% 854
2016
Q2 		– Sell
-7
Closed – – 454
2016
Q1 		$0 Sell
7
-79
-92% -$4.64K ﹤0.01% 625
2015
Q4 		$6K Buy
+86
New +$5.32K ﹤0.01% 447

Other funds holding TEVA

Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sound Shore Management
Sound Shore Management Greenwich, Connecticut $3.2B AUM 19.02% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Asset Dedication LLC's TEVA Position: Q3 2026 in Review

Asset Dedication LLC sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 198 shares — an estimated $6.71K sold.

Asset Dedication LLC first reported a position in TEVA in Q4 2015 and held it in 3 quarters. The position peaked at $6.71K in Q2 2026. 261 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Asset Dedication LLC reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • Asset Dedication LLC sold 198 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $6.71K.
  • Asset Dedication LLC first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 3 quarters.
  • Asset Dedication LLC's Teva Pharmaceutical Industries Limited position peaked at $6.71K in Q2 2026.
  • 261 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Asset Dedication LLC's 13F filing for Q3 2026, filed 3 Nov 2026.